Jason Murray Hulse, Co-Founder, CEO, and Chairman of PACS Group, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 19,235 shares of common stock on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Jason Murray Hulse, identified as Co-Founder, CEO, and Chairman, as well as a Director and 10% Owner of PACS Group, Inc.
  • First transaction: 17,822 shares disposed of on November 5, 2026, at a weighted average price of $50.6016 per share, in multiple transactions ranging from $50.00 to $50.99 per share.
  • Second transaction: 1,413 shares disposed of on November 5, 2026, at a weighted average price of $51.101 per share, in multiple transactions ranging from $51.00 to $51.29 per share.
  • Post-transaction ownership: Hulse directly beneficially owned 53,934,866 shares of common stock following the reported transactions.
  • 10b5-1 plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Hulse on May 18, 2026.
  • Exchange and ticker: The issuer is listed as PACS Group, Inc. (PACS), with no exchange name provided in the filing's issuer field.

Hulse's November 5 Share Sales Under Pre-Established Trading Plan

According to the filing, Jason Murray Hulse, who serves as Co-Founder, CEO, and Chairman of PACS Group, Inc., reported two dispositions of common stock on November 5, 2026. The first transaction involved 17,822 shares sold at a weighted average price of $50.6016, with individual sales occurring at prices ranging from $50.00 to $50.99 per share. The second transaction covered 1,413 shares sold at a weighted average price of $51.101, with prices in that tranche ranging from $51.00 to $51.29 per share.

The filing disclosed that both transactions were conducted under a Rule 10b5-1 trading plan that Hulse adopted on May 18, 2026. The filing noted that the box indicating a Rule 10b5-1(c) plan was checked. Because both prices are weighted averages across multiple transactions, the filing states that Hulse undertakes to provide full information regarding the number of shares sold at each separate price within each range, upon request by the issuer, any security holder, or the SEC staff.

Following the two reported transactions, Hulse's direct beneficial ownership of PACS Group common stock stood at 53,934,866 shares, according to the filing. Hulse signed the form through Trevor Petersen, Attorney-in-Fact, on November 9, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

PACS Group Co-Founder, CEO, and Chairman Jason Murray Hulse disclosed the sale of a combined 19,235 shares of common stock on November 5, 2026, under a pre-established Rule 10b5-1 trading plan, leaving him with direct beneficial ownership of 53,934,866 shares.